Trial Details
UNKNOWNBasic Information
| Clinical ID | c1811 |
|---|---|
| Identifier | NCT04422171 |
| Trial Title | A 12-month Real Life Study of IBD Patients Switched From Adalimumab Originator Humira® to One of Its Biosimilar |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | IBD Patients, Originator Treatment, Biosimilar, Switch Back |
| Interventions | - |
Participant Information
| Sponsor | University Hospital, Grenoble |
|---|---|
| City | Grenoble |
| Country/Region | France |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | NULL |
Time Information
| Start Date | 2020-06-19 |
|---|---|
| Primary Completion Date | 2021-06-18 |
| Completion Date | 2023-01-31 |